Next Issue

November 2023

Don’t miss out – sign up to our free industry-leading magazine and newsletters

In the next issue, we explore how groups are trying to fix the biases of generative artificial intelligence as the pharma industry continues to explore its applications.

EDITORIAL

Editor |Manasi Vaidya, Irena Maragkou

Writers | Abigail Beaney, Phalguni Deswal, Cyrus Fan, Urte Fultinaviciute, Adam Zamecnik

Graphic Designers | Anett Arc, Noemi Balint, Will Ingham, Miriam Garofalo

Publisher | Susanne Hauner

ADVERTISING

Sales Manager | Tom McCormick
+44 207 8669440

Cover image credit: Getty Images/Peter Dazeley

Pharma Technology Focus is powered by H5mag
Read past issues of Pharma Technology Focushere

Go to article: Home | How pharma wants to break the efficacy ceiling in IBDGo to article: Editor's letterGo to article: ContentsGo to article: Mimotopes Company InsightGo to article: MimotopesGo to article: UrsatecGo to article: SHL Medical Company InsightGo to article: SHL MedicalGo to article: ControlantGo to article: BriefingGo to article: News in NumbersGo to article: Latest NewsGo to article: Latest DealsGo to article: Project UpdatesGo to article: Trends & InsightGo to article: Owen Mumford Company InsightGo to article: Owen MumfordGo to article:  Sensified.ioGo to article: In DepthGo to article: How pharma wants to break the efficacy ceiling in IBDGo to article: Subcutaneous drugs grant a new lease on life to checkpoint inhibitorsGo to article: Hope for the UK clinical trial landscape but it requires a lot of work Go to article: Novo Nordisk’s Wegovy to start being supplied by NHS in EnglandGo to article: Minimal impact expected for first ten drugs released for Medicare price negotiationGo to article: Q&A: Human touch remains critical for the patient experience in trialsGo to article: Zenatek Company InsightGo to article: BEA TechnologiesGo to article: ListingsGo to article: EventsGo to article: AwardsGo to article: Buyer's GuidesGo to article: Next issue